- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07562919
Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed in Geriatric Individuals
25. april 2026 oppdatert av: Gulfidan Tokgoz, Istanbul University - Cerrahpasa
Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed Threshold Values in Geriatric Individuals
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over.
The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand grip), dynamic balance (FUT), functional mobility (TUG), and stair climbing/climbing skills in individuals with walking speeds of 0.4-0.8
m/s (limited community mobility) and above 0.8 m/s (independent community mobility).
Studieoversikt
Status
Har ikke rekruttert ennå
Intervensjon / Behandling
Detaljert beskrivelse
Although the relationships between walking speed and individual physical parameters have been studied in the geriatric literature, comprehensive analyses comparing multidimensional parameters such as flexibility, static-dynamic balance, hand grip strength, and stair activity performance in groups separated according to walking speed threshold values (0.4-0.8 m/s and >0.8 m/s) are needed.
This study aims to identify which physical components show the most significant deficits when walking speed decreases, thereby providing a scientific basis for clinical assessment processes and personalized preventive rehabilitation programs.
Studietype
Observasjonsmessig
Registrering (Antatt)
76
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Telefonnummer: 0552 022 76 32
- E-post: gulfidan.tokgoz@gmail.com
Studiesteder
-
-
-
Balıkesir, Tyrkia (Türkiye)
- Balıkesir University
-
Ta kontakt med:
- GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Telefonnummer: 0552 022 76 32
- E-post: gulfidan.tokgoz@gmail.com
-
Underetterforsker:
- Bilal Katipoğlu, Assoc. Prof. Dr.
-
Ta kontakt med:
- Nilay ARMAN, Assoc. Prof. Dr.
- Telefonnummer: +905534558707
-
Underetterforsker:
- Saime Nilay Arman, Assoc. Prof. Dr.
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Eldre voksen
Tar imot friske frivillige
Ja
Prøvetakingsmetode
Sannsynlighetsprøve
Studiepopulasjon
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
Beskrivelse
Inclusion Criteria:
- Being 65 years of age or older
- Being able to perform walking functions
- Having sufficient mobility to perform the physical performance tests included in the research, such as 5 sit-stand tests, TUG (Trip and Go) tests, and stair climbing/descending tests. • Having a walking speed of at least 0.4 m/s or more as a result of the 4 Meter Walking Test (having limited or independent mobility within the community).
- Voluntarily agreeing to participate in the study and providing informed consent.
Exclusion Criteria:
- Having a history of advanced cognitive impairment or diagnosed dementia that would impair the ability to understand and follow test instructions.
- Those diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Having a walking speed below 0.4 m/s on the 4-Meter Walk Test (individuals who are wheelchair-bound or bedridden).
- Advanced Parkinson's disease, active stroke sequelae, lower extremity fracture within the last 6 months, or a history of acute orthopedic surgery that primarily affects motor performance and balance.
- Those with severe hearing or vision loss
- Individuals experiencing significant difficulty communicating
- Participants who did not sign the voluntary consent form
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Geriartric Indivıduals
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
|
Assessments will be conducted after obtaining voluntary consent from the participants.
The physical performance tests to be applied within the scope of the research will be carried out by the research team within the framework of internationally accepted standard protocols whose validity and reliability have been proven in the geriatric population.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
4-Meter Walk Test (Walking Speed Measurement)
Tidsramme: 1 week
|
Walking speed will be assessed using the 4-Meter Walk Test, a key indicator of functional mobility in geriatric individuals.
Participants will be asked to walk a 4-meter test area in the center at their "natural and comfortable walking speed," using 1-meter "acceleration" zones at the beginning and 1-meter "deceleration" zones at the end of a 6-meter flat course.
The measurement will be recorded with a stopwatch the moment the participant's foot crosses the 4-meter marked area, and the result will be calculated in m/s (Studenski et al., 2011).
|
1 week
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Time Sit-Stand Test (5STS):
Tidsramme: 1 week
|
To assess lower extremity muscle strength and balance, participants will be asked to stand up and sit down as quickly as possible, five times consecutively, from a standard chair 43-45 cm high, with their arms crossed over their chest.
The timer will start with the "start" command and end when the fifth sitting is completed (Bohannon, 2006).
|
1 week
|
|
Timed Up and Go (TUG):
Tidsramme: 1 week
|
To measure functional mobility, the participant will get up from the chair, walk a distance of 3 meters, return, and sit back down in the chair.
This time will be recorded in seconds using a stopwatch (Podsiadlo & Richardson, 1991).
|
1 week
|
|
Functional Reach Test (FUT/FRT)
Tidsramme: 1 week
|
To measure static balance and stability limits, the maximum distance the participant can reach without losing balance and without taking a step, while standing next to a wall with the shoulder flexed at 90 degrees, will be measured (Duncan et al., 1990).
|
1 week
|
|
Single Leg Balance Test (Right and Left):
Tidsramme: 1 week
|
Participants' static balance will be determined by recording the "time they can stand on one leg" (maximum 60 seconds) with their eyes open and hands on their hips, on both their dominant and non-dominant legs (Springer et al., 2007).
|
1 week
|
|
Flexibility (Sit-and-Reach Test):
Tidsramme: 1 week
|
To measure hamstring and lower back flexibility, the participant will sit in a long, straight position, reaching forward without bending their knees.
The distance reached by their fingertips will be recorded on a "sit-and-reach bench" (Wells & Dillon, 1952).
|
1 week
|
|
Stair Climbing Test
Tidsramme: 1 week
|
To assess high-level mobility, participants will be recorded in seconds for safely and as quickly as possible ascending and descending a staircase of standard step height [a specified number of steps, e.g., 10 steps] (Nightingale et al., 2003).
|
1 week
|
|
Strength Measurement (Hand Grip Strength):
Tidsramme: 1 week
|
Upper extremity muscle strength will be measured using a digital hand dynamometer according to the ASHT (American Society of Hand Therapists) protocol.
Participants will be asked to grip with maximum force while sitting upright, with shoulder adduction and elbow 90 degrees flexed.
Three repetitions will be performed for each hand, and the average of these measurements in kilograms (kg) will be included in the analysis (Roberts et al., 2011; Cruz-Jentoft et al., 2019).
|
1 week
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. doi: 10.1007/s12603-009-0246-z.
- Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. mai 2026
Primær fullføring (Antatt)
15. mai 2026
Studiet fullført (Antatt)
30. august 2026
Datoer for studieregistrering
Først innsendt
25. april 2026
Først innsendt som oppfylte QC-kriteriene
25. april 2026
Først lagt ut (Faktiske)
1. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
1. mai 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
25. april 2026
Sist bekreftet
1. april 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 2026/46
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .